# Schizophrenia Treatment Adherence Investigation (STAI)

> **NCT01001481** · — · COMPLETED · sponsor: **Janssen-Cilag Pty Ltd** · enrollment: 550 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **OTHER:** Risk status for medication adherence

## Key facts

- **NCT ID:** NCT01001481
- **Lead sponsor:** Janssen-Cilag Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2014-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01001481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01001481, "Schizophrenia Treatment Adherence Investigation (STAI)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01001481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*